We are live on ! Find out more
Jarislowsky, Fraser

Jarislowsky, Fraser Portfolio holdings

AUM $18.2B Turnover 3.11%
1-Year Est. Return 22.04%
 

Jarislowsky Fraser started in 1955 as a Montreal research firm that sold its stock research to investment managers in the US and UK. Its founder, Stephen Jarislowsky, was a Harvard-educated investor and former Alcan executive. The firm won its first pension fund client by 1966, and managing money for institutions became its core business. Scotiabank bought it in 2018, and the firm kept its Montreal headquarters and its investment independence. It looks for quality, sustainable businesses to hold for long-term growth, and serves pension funds, endowments, foundations, corporations and Indigenous communities.

This Fund
S&P 500
This Quarter Est. Return
-1.04%
1 Year Est. Return
+22.04%
3 Year Est. Return
+92.62%
5 Year Est. Return
+122.31%
10 Year Est. Return
+241.46%
AUM
$14.7B
AUM Growth
-$298M
Cap. Flow
+$61.8M
Cap. Flow %
0.42%
Top 10 Hldgs %
47.54%
Holding
147
New
1
Increased
42
Reduced
93
Closed
3
Avg Time Held
1.8 years
Top 10 Avg Time Held
1.6 years
Top 20 Avg Time Held
1.5 years

Top Buys

Rank Stock Value
1
GIL icon
Gildan
GIL
+$134M
2
STN icon
Stantec
STN
+$84.5M
3
IMS
IMS HEALTH HLDGS INC COM STK (DE)
IMS
+$43.5M
4
OTEX icon
Open Text
OTEX
+$37.1M
5
TJX icon
TJX Companies
TJX
+$20.4M

Top Sells

Rank Stock Value
1
BNS icon
Scotiabank
BNS
+$30.3M
2
TD icon
Toronto Dominion Bank
TD
+$27.9M
3
RY icon
Royal Bank of Canada
RY
+$24.8M
4
AGN
Allergan plc
AGN
+$19.2M
5
ENB icon
Enbridge
ENB
+$16.4M

Sector Composition

Rank Sector Weight
1 Financials 31.13%
2 Energy 23.04%
3 Industrials 13.63%
4 Technology 9.6%
5 Healthcare 8.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TD icon
1
Toronto Dominion Bank
TD
$202B
$1.12B 7.64%
26,382,319
-622,371
-2% -$27.9M
2013 Q2
8 quarters
RY icon
2
Royal Bank of Canada
RY
$280B
$1.04B 7.07%
16,982,342
-385,871
-2% -$24.8M
2013 Q2
8 quarters
BNS icon
3
Scotiabank
BNS
$113B
$904M 6.16%
18,319,316
-593,838
-3% -$30.3M
2013 Q2
8 quarters
ENB icon
4
Enbridge
ENB
$106B
$634M 4.32%
13,540,935
-330,865
-2% -$16.4M
2013 Q2
8 quarters
CNI icon
5
Canadian National Railway
CNI
$76.3B
$631M 4.3%
10,919,189
-216,287
-2% -$13.5M
2013 Q2
8 quarters
MFC icon
6
Manulife Financial
MFC
$72.8B
$615M 4.19%
33,089,828
-553,994
-2% -$10.3M
2013 Q2
8 quarters
SU icon
7
Suncor Energy
SU
$80.5B
$603M 4.11%
21,886,960
-481,504
-2% -$14.6M
2013 Q2
8 quarters
TRI icon
8
Thomson Reuters
TRI
$47.4B
$511M 3.48%
11,567,410
-289,428
-2% -$13.6M
2013 Q2
8 quarters
CNQ icon
9
Canadian Natural Resources
CNQ
$101B
$511M 3.48%
38,932,671
-898,885
-2% -$13.5M
2013 Q2
8 quarters
CVE icon
10
Cenovus Energy
CVE
$52.6B
$410M 2.79%
25,627,274
-360,060
-1% -$6.27M
2013 Q2
8 quarters
OTEX icon
11
Open Text
OTEX
$6B
$353M 2.41%
17,388,752
+1,540,908
+10% +$37.1M
2013 Q2
8 quarters
CCJ icon
12
Cameco
CCJ
$30.8B
$246M 1.67%
17,173,524
-361,510
-2% -$5.71M
2013 Q2
8 quarters
STN icon
13
Stantec
STN
$9.48B
$235M 1.6%
8,048,052
+3,079,975
+62% +$84.5M
2013 Q2
8 quarters
PBA icon
14
Pembina Pipeline
PBA
$29.3B
$220M 1.5%
6,797,563
+85,787
+1% +$2.87M
2013 Q3
7 quarters
GIL icon
15
Gildan
GIL
$6.42B
$219M 1.49%
6,586,896
+4,171,602
+173% +$134M
2015 Q1
1 quarter
JNJ icon
16
Johnson & Johnson
JNJ
$688B
$219M 1.49%
2,242,105
-25,670
-1% -$2.57M
2013 Q2
8 quarters
GIB icon
17
CGI
GIB
$16.7B
$217M 1.48%
5,554,511
-2,827
-0.1% -$122K
2014 Q4
2 quarters
VET icon
18
Vermilion Energy
VET
$1.66B
$213M 1.45%
4,918,813
-110,208
-2% -$4.98M
2014 Q3
3 quarters
POT
19
DELISTED
Potash Corp Of Saskatchewan
POT
$205M 1.4%
6,632,045
-384,776
-5% -$12.3M
2013 Q2
8 quarters
WBA icon
20
DELISTED
Walgreens Boots Alliance
WBA
$205M 1.4%
2,425,950
+10,683
+0.4% +$921K
2013 Q2
8 quarters
PG icon
21
Procter & Gamble
PG
$394B
$187M 1.27%
2,392,161
-22,125
-0.9% -$1.78M
2013 Q2
8 quarters
PEP icon
22
PepsiCo
PEP
$198B
$179M 1.22%
1,917,311
-23,913
-1% -$2.29M
2013 Q2
8 quarters
CVS icon
23
CVS Health
CVS
$114B
$176M 1.2%
1,681,751
-10,344
-0.6% -$1.06M
2013 Q2
8 quarters
WFC icon
24
Wells Fargo
WFC
$258B
$176M 1.2%
3,132,228
-34,079
-1% -$1.9M
2013 Q2
8 quarters
JPM icon
25
JPMorgan Chase
JPM
$919B
$174M 1.18%
2,566,557
-34,734
-1% -$2.27M
2013 Q2
8 quarters

Similar funds

Jarislowsky, Fraser's Q2 2015 Portfolio in Review

As of Q2 2015, Jarislowsky, Fraser held 147 positions worth $14.7B, down 2% from $15B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Trading was light in Q2 2015: portfolio turnover was 2.7%. Jarislowsky, Fraser opened 1 new position and exited 3, leaving the 147-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 30% a quarter earlier, followed by Energy and Industrials.

  • Jarislowsky, Fraser's largest Q2 2015 buy was Capital One: 20,257 shares worth $1.78M.
  • Jarislowsky, Fraser added most to Gildan in Q2 2015, an estimated $134M increase.
  • Jarislowsky, Fraser's biggest Q2 2015 reduction was Scotiabank, cutting an estimated $30.3M.
  • Jarislowsky, Fraser fully exited Allergan plc in Q2 2015, selling an estimated $19.2M.
  • Jarislowsky, Fraser's ten largest holdings make up 48% of its $14.7B portfolio in Q2 2015.
  • Jarislowsky, Fraser opened 1 new position and closed 3 in Q2 2015.
  • Jarislowsky, Fraser's portfolio value fell 2% quarter-over-quarter to $14.7B.

Based on Jarislowsky, Fraser's 13F filing for Q2 2015, filed 11 Aug 2015.